CYAN (OTC)
CYANOTECH CORP
$0.389500
+0.053600 (+15.96%)
Prev close: $0.335900
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Matthew K. Custer
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $2.88M
- Employees
- 83
- P/E (TTM)
- -1.66
- P/B (TTM)
- 0.39
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $25.27M |
| Benefits Costs and Expenses | $27.04M |
| Cost Of Revenue | $17.18M |
| Costs And Expenses | $27.04M |
| Gross Profit | $8.09M |
| Operating Expenses | $9.14M |
| Research and Development | $380.00K |
| Other Operating Expenses | $8.05M |
| Operating Income/Loss | -$1.06M |
| Income/Loss From Continuing Operations After Tax | -$1.78M |
| Income/Loss From Continuing Operations Before Tax | -$1.77M |
| Income Tax Expense/Benefit | $8.00K |
| Interest Expense, Operating | $713.00K |
| Net Income/Loss | -$1.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.24 |
| Basic Average Shares | 21,695,000 |
| Assets | $24.03M |
| Current Assets | $11.93M |
| Inventory | $8.38M |
| Other Current Assets | $3.55M |
| Noncurrent Assets | $12.10M |
| Fixed Assets | $8.35M |
| Other Non-current Assets | $3.74M |
| Liabilities | $15.96M |
| Current Liabilities | $11.89M |
| Accounts Payable | $2.97M |
| Other Current Liabilities | $8.92M |
| Noncurrent Liabilities | $4.07M |
| Long-term Debt | $4.22M |
| Equity | $8.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.07M |
| Liabilities And Equity | $24.03M |
| Net Cash Flow From Operating Activities | -$1.21M |
| Net Cash Flow From Operating Activities, Continuing | -$1.21M |
| Net Cash Flow From Investing Activities | -$228.00K |
| Net Cash Flow From Investing Activities, Continuing | -$228.00K |
| Net Cash Flow From Financing Activities | $1.31M |
| Net Cash Flow From Financing Activities, Continuing | $1.31M |
| Net Cash Flow | -$131.00K |
| Net Cash Flow, Continuing | -$131.00K |
| Comprehensive Income/Loss | -$1.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.78M |
| Other Comprehensive Income/Loss | $0.00 |